日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?

多发性硬化症病灶的异质性:我们如何评估和改变退行性病灶?

Ellen, Olivia; Ye, Sining; Nheu, Danica; Dass, Mary; Pagnin, Maurice; Ozturk, Ezgi; Theotokis, Paschalis; Grigoriadis, Nikolaos; Petratos, Steven

Nogo receptor-Fc delivered by haematopoietic cells enhances neurorepair in a multiple sclerosis model

造血细胞递送的Nogo受体-Fc可增强多发性硬化症模型中的神经修复。

Sining Ye ,Paschalis Theotokis ,Jae Young Lee ,Min Joung Kim ,Danica Nheu ,Olivia Ellen ,Thomas Bedford ,Padmanabhan Ramanujam ,David K Wright ,Stuart J McDonald ,Amani Alrehaili ,Maha Bakhuraysah ,Jung Hee Kang ,Christopher Siatskas ,Cedric S Tremblay ,David J Curtis ,Nikolaos Grigoriadis ,Mastura Monif ,Stephen M Strittmatter ,Steven Petratos

Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis

调节小胶质细胞Nogo-A/NgR信号通路作为多发性硬化症的治疗靶点

Nheu, Danica; Ellen, Olivia; Ye, Sining; Ozturk, Ezgi; Pagnin, Maurice; Kertadjaja, Stephen; Theotokis, Paschalis; Grigoriadis, Nikolaos; McLean, Catriona; Petratos, Steven

Single live cell TGF-β signalling imaging: breast cancer cell motility and migration is driven by sub-populations of cells with dynamic TGF-β-Smad3 activity

单细胞TGF-β信号成像:乳腺癌细胞的运动性和迁移是由具有动态TGF-β-Smad3活性的细胞亚群驱动的。

Luwor, Rodney B; Hakmana, Dulani; Iaria, Josephine; Nheu, Thao V; Simpson, Richard J; Zhu, Hong-Jian

SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor

SPSB1 是一种靶向 II 型受体的转化生长因子-β 信号通路的新型负调节剂

Sheng Liu, Thao Nheu, Rodney Luwor, Sandra E Nicholson, Hong-Jian Zhu